BILL · 2017–18 SESSION
SB 5626: Step therapy/stage 4 cancer
Prohibiting the use of step therapy in treatments for stage four advanced, metastatic cancer.
Summary
- Prohibits the use of step therapy in the treatment of metastatic cancer.
From the Senate Bill Report (Orig.) (SB 5626), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedFeb 1, 2017
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Mark Miloscia (R-30)
- Introduced
- February 1, 2017 in the Senate
- Last action
- January 8, 2018
- Budget
- Has a fiscal note
AN ACT Relating to prohibiting the use of step therapy in treatments for stage four advanced, metastatic cancer;
Sponsors
Prime sponsor: Mark Miloscia (R-30)
2 co-sponsors (1 Democrat, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- Due to Senate committee reorganization, referred to Health & Long Term Care.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care.
SB 5626 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5626 (2025–26) Wage replacement
- SB 5626 (2023–24) K-12 media literacy
- SB 5626 (2021–22) Water system plans/climate
- SB 5626 (2019–20) Cultivation of shellfish
- SB 5626 (2015–16) Health benefit exchange data
- SB 5626 (2013–14) Midwifery
- SB 5626 (2011–12) Education & arts access prog
- SB 5626 (2009–10) Additional cigarette tax